Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Operating Leases (2020 - 2025)

Historic Operating Leases for P3 Health Partners (PIII) over the last 5 years, with Q3 2025 value amounting to $12.1 million.

  • P3 Health Partners' Operating Leases rose 802.12% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 million, marking a year-over-year increase of 802.12%. This contributed to the annual value of $11.3 million for FY2024, which is 1675.97% down from last year.
  • According to the latest figures from Q3 2025, P3 Health Partners' Operating Leases is $12.1 million, which was up 802.12% from $10.3 million recorded in Q2 2025.
  • Over the past 5 years, P3 Health Partners' Operating Leases peaked at $13.6 million during Q4 2023, and registered a low of $6.3 million during Q1 2022.
  • In the last 4 years, P3 Health Partners' Operating Leases had a median value of $11.5 million in 2022 and averaged $11.5 million.
  • Its Operating Leases has fluctuated over the past 5 years, first skyrocketed by 10263.18% in 2023, then tumbled by 1768.96% in 2024.
  • Over the past 4 years, P3 Health Partners' Operating Leases (Quarter) stood at $11.5 million in 2022, then increased by 18.29% to $13.6 million in 2023, then decreased by 16.76% to $11.3 million in 2024, then rose by 6.3% to $12.1 million in 2025.
  • Its Operating Leases was $12.1 million in Q3 2025, compared to $10.3 million in Q2 2025 and $11.0 million in Q1 2025.